TELA Bio Inc
TELA
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.37M
Close$
$2.57
106.9% upside
Current Fair Value
106.9% upsideUndervalued by 106.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.37 Million |
|---|---|
| Enterprise Value | $82.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1.36 |
| Outstanding Shares | 57,414,360 |
Return
| Return on Equity | 259.54% |
|---|---|
| Return on Assets | -68.93% |
| Return on Invested Capital | -81.54% |
Valuation & Multiples
| P/E Ratio | -1.64 |
|---|---|
| PEG | -12.13 |
| Price to Sales | 1.24 |
| Price to Book Ratio | -1.24 |
| Enterprise Value to Revenue | 1.03 |
| Enterprise Value to EBIT | -2.44 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.69 |
| Debt to Equity | -3.57 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$20.01 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$20.03 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.84%▼ 2.09% |
|---|---|
| Total Invested | $19.33M▲ 15.65% |
| Investors Holding | 44▲ 8.00% |
ESG Score
No data